Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MTC INVITRO is a Germany-based in vitro diagnostics company focused on immunohematology and blood grouping workflows for blood banks, donor centers, hospitals, and clinical laboratories. The company markets gel centrifugation systems, microplate-based blood grouping products, conventional liquid reagents, rapid tests, and automated analyzers for pretransfusional analysis. Its core commercial platform is the INVITROGEL TEST-SYSTEM, supported by instruments and accessories under the INVITROLYZER family. MTC traces its roots to Micro Typing Concepts, founded in 1987, and positions its international arm, MTC INVITRO DIAGNOSTICS AG, as the global distribution and commercialization organization. The business appears to be fully commercial rather than a therapeutic drug developer, with revenue derived from diagnostic products and laboratory instrumentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MTC INVITRO.